Does anti-mullerian hormone (AMH) predict biochemical hyperandrogenism, oligo-anovulation (OA), metabolic dysfunction (MD), and metabolic syndrome (METS)?: results from a longitudinal study
AMH is established as a biomarker of ovarian reserve. Prior data suggests that AMH may be predictive of Polycystic Ovarian Syndrome (PCOS) and MetS.
Source: fertstert.org
Does anti-mullerian hormone (AMH) predict biochemical hyperandrogenism, oligo-anovulation (OA), metabolic dysfunction (MD), and metabolic syndrome (METS)?: results from a longitudinal study
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
Be First to Comment